Ewa Bar‐Andziak

Lymphoid tyrosine phosphatase (<i>PTPN22</i>/LYP) variant and Graves’ disease in a Polish population: association and gene dose‐dependent correlation with age of onset

Agata Skórka, Tomasz Bednarczuk, Ewa Bar‐Andziak et al. · Clinical Endocrinology · 2005 · 127 citations

Life Sciences, Genetics, Molecular Genetics +16

Association of NFKB1 −94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease

Yuji Hiromatsu, Beata Jurecka‐Lubieniecka, Dorota Kula et al. · Genes and Immunity · 2007 · 44 citations

Life Sciences, Genetics, Molecular Genetics +11

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency - management in adults.

Urszula Ambroziak, Tomasz Bednarczuk, Maria Ginalska-Malinowska et al. · PubMed · 2010 · 39 citations

Life Sciences, Biochemistry, Endocrinology +17

Polymorphism of the oestrogen receptor beta gene (<i>ESR2</i>) is associated with susceptibility to Graves’ disease

Bartłomiej Kisiel, Tomasz Bednarczuk, Grażyna Kostrzewa et al. · Clinical Endocrinology · 2007 · 31 citations

Life Sciences, Endocrinology, Genetics +17

[Management of thyroid diseases during pregnancy].

Alicja Hubalewska–Dydejczyk, Andrzej Lewiñski, Andrzej Milewicz et al. · PubMed · 2011 · 31 citations · Full text

Medicine, Endocrinology, Obstetrics +17